Concepedia

Erick W. Co

EW

Statistics

Publications

4

Citations

123

H-Index

4

Active since

2012

Affiliations

Exelixis (United States)(Current)

Erick W. Co is an author at Exelixis (United States) specializing in pharmacology, enzyme inhibition, and potency optimization.

Publications per year

2012–2012

4

Publications

4

Effect of molecular weight of PGG–paclitaxel conjugates on in vitro and in vivo efficacy

Danbo Yang, Xiaoqing Liu, Xinguo Jiang et al. · Journal of Controlled Release · 2012 · 43 citations

, , +16

The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors

Moon H. Kim, Amy Lew Tsuhako, Erick W. Co et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations · Full text

, , +14

Pyrazolopyrimidines as dual Akt/p70S6K inhibitors

Kenneth D. Rice, Moon H. Kim, Joerg Bussenius et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations · Full text

, , +8

Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors

Joerg Bussenius, Neel K. Anand, Charles M. Blazey et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 24 citations · Full text

, , +10

1–4 of 4